D

Dare Bioscience
D

DARE

2.40000
USD
0.02
(0.84%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-14
حجم السوق
21,240,926
أصول ذات صلة
A
ACAD
-0.285
(-1.34%)
20.955 USD
I
IFRX
0.01690
(2.11%)
0.81690 USD
K
KALA
-0.02000
(-0.39%)
5.16000 USD
P
PRFX
-0.01700
(-1.20%)
1.40000 USD
S
STEM
1.07000
(14.25%)
8.58000 USD
المزيد
الأخبار المقالات

العنوان: Dare Bioscience Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatmentof bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.